New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part II.
Recent developments in the rapidly advancing area of neuroprotection and neuroregeneration necessitated the need to gather over 50 of the world's leading experts under the umbrella of the Global College of Neuroprotection and Neuroregeneration in its 7th Annual Meeting in Stockholm, Sweden. In this meeting, top policy-makers, together with world leaders in pharmaceutical industries, discussed the urgent need to develop new pharmaceuticals, as well as using a combination of existing ones, to treat CNS disorders in order to improve the current status of healthcare. In addition, nanobiotechnologists proposed the use of a new formulation of drugs using nanotechnologies for enhanced drug delivery to the brain for better therapeutic efficacy of the neuroprotective agents. The deliberations in this meeting provide new perspectives on the molecular and cellular mechanisms of neuroprotection and neuroregeneration that could be utilized to improve the existing healthcare for the benefit of mankind.
Sharma
Hari Shanker
HS
Department of Surgical Sciences, University Hospital, Uppsala University, Uppsala, Sweden. sharma@surgsci.uu.se
Sharma
Aruna
A
D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D004345:Drug Industry / Q000639:trends; D006801:Humans; D050997:Nanomedicine; D009416:Nerve Regeneration / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000008:administration & dosage* / Q000494:pharmacology*
D018696:Neuroprotective Agents